Biomarkers · Inflammation
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
Lower values carry lower risk. Not measured in our NHANES panel; the curve is synthesised from the published association.
Hazard ratio relative to the curve's reference value, as synthesised from the published association.
Published hazard ratio1.45top vs bottom quarter (95% CI 1.05–2.00) · CKD-focused cohorts
Where people sit
Population percentiles (ng/mL) by sex and age band. Cycle or source as recorded in the catalogue.
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 1.84 | 2.48 | 3.13 | 3.96 | 5.70 | 9,305 | Haupt TH, Rasmussen LJ… |
| All | 40-59 | 2.00 | 2.70 | 3.40 | 4.30 | 6.20 | 9,305 | Haupt TH, Rasmussen LJ… |
| All | 60+ | 2.18 | 2.94 | 3.71 | 4.69 | 6.76 | 9,305 | Haupt TH, Rasmussen LJ… |
| All | all | 2.00 | 2.70 | 3.40 | 4.30 | 6.20 | 9,305 | Haupt TH, Rasmussen LJ… |
| Men | all | 1.74 | 2.44 | 3.10 | 3.93 | 5.54 | 9,305 | Haupt TH, Rasmussen LJ… |
| Women | all | 1.96 | 2.73 | 3.44 | 4.33 | 6.03 | 9,305 | Haupt TH, Rasmussen LJ… |
Sources
- Hazard curve: Synthesized from mortality_association (HR=1.45 quartile_extreme); per-SD log(HR)=0.290. Q4 vs Q1 for suPAR; kidney disease progression and mortality
- Establishing reference intervals for soluble urokinase plasminogen activator receptor in Northern European adults
Map Soluble Urokinase Plasminogen Activator Receptor (suPAR) against another biomarker.